From NAFLD to MASLD: When metabolic comorbidity matters
Steatosis
Hepatic fibrosis
DOI:
10.1016/j.aohep.2023.101281
Publication Date:
2023-12-21T10:39:19Z
AUTHORS (8)
ABSTRACT
In a recent development, cohort of hepatologists has proposed altering the nomenclature non-alcoholic fatty liver disease (NAFLD) to metabolic-associated steatotic (MASLD), accompanied by modified diagnostic criteria. Our objective was investigate effect revised definition on identifying significant hepatic fibrosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (14)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....